Seizures benign familial neonatal recessive form

Seizures Benign Familial Neonatal, Recessive Form (BFNIS) is a neurological condition characterized by the occurrence of seizures in newborns within the first days to months of life. These seizures are typically non-life-threatening and tend to resolve spontaneously within the first year of life. The condition is termed "benign" due to its generally favorable prognosis and "familial" because it tends to run in families, indicating a genetic basis. The "recessive form" refers to the mode of inheritance, meaning that the condition occurs when a child inherits two copies of the mutated gene, one from each parent, who are usually not affected themselves.

Genetics

BFNIS is caused by mutations in specific genes. The most commonly implicated gene in the recessive form is KCNT1, which encodes for a sodium-activated potassium channel involved in the regulation of neuronal excitability. Mutations in this gene disrupt the normal function of the channel, leading to increased neuronal excitability and, consequently, seizures. As a recessive disorder, both parents must carry one copy of the mutated gene to pass the condition onto their child.

Clinical Presentation

Infants with BFNIS typically present with seizures within the first days to weeks of life. These seizures are often characterized by clonic movements of the limbs, apnea, and, in some cases, autonomic manifestations such as changes in heart rate or blood pressure. The seizures are usually brief and can occur multiple times a day.

Diagnosis

The diagnosis of BFNIS is primarily clinical, based on the characteristic presentation of seizures in the neonatal period and a family history of similar conditions. Electroencephalogram (EEG) findings during this period may show specific patterns that support the diagnosis. Genetic testing can confirm the diagnosis by identifying mutations in the associated genes.

Treatment

Treatment for BFNIS is usually symptomatic and may include antiepileptic drugs (AEDs) to control seizures. However, in many cases, the seizures spontaneously resolve within the first year of life, and treatment may no longer be necessary.

Prognosis

The prognosis for infants with BFNIS is generally favorable. Most children outgrow the seizures without developing significant neurological deficits. However, long-term follow-up studies are needed to fully understand the outcomes of individuals with this condition.

Epidemiology

BFNIS is a rare condition, and the exact incidence is not well established. It is considered less common than the dominant form of benign familial neonatal seizures.

Seizures benign familial neonatal recessive form Resources
Latest articles Most recent articles Ongoing trials	Wikipedia